Search research articles
Contact Us
Filters
Showing results (101-110 of 182) with videos related to
Page
of 19
Sort By:
Oncotarget
|
April 29, 2016
Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling
Benjamin Y Owusu, Namita Bansal, Phanindra K M Venukadasula, et al.
Gynecologic Oncology
|
July 24, 2013
Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: a single institution experience from 1999 to 2010
June Y Hou, Santiago Aparo, Mohammad Ghalib, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
October 12, 2022
Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma
Ana Acuna-Villaorduna, Viswanathan Shankar, Michael Wysota, et al.
Investigational New Drugs
|
August 21, 2024
Targeting multiple receptor tyrosine kinases with sitravatinib: A Phase 1b study in advanced renal cell carcinoma and castrate-resistant prostate cancer
Shubham Pant, Byoung Chul Cho, Christos E Kyriakopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2010
Phase II study on the addition of ASA404 (vadimezan; 5,6-dimethylxanthenone-4-acetic acid) to docetaxel in CRMPC
Roberto Pili, Mark A Rosenthal, Paul N Mainwaring, et al.
Molecules (Basel, Switzerland)
|
August 27, 2021
Evaluation of the Free Radical Scavenging Activities of Ellagic Acid and Ellagic Acid Peracetate by EPR Spectrometry
Ajit Kumar, Preeti Kaushik, Sandra Incerpi, et al.
Frontiers in Genetics
|
November 17, 2022
Metformin: Activation of 5' AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action
Sanjay Goel, Ravinder Singh, Varinder Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2020
A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma
Sant P Chawla, Sanjay Goel, Warren Chow, et al.
American Journal of Clinical Oncology
|
September 10, 2009
Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma
Anthony P Lam, Joseph A Sparano, Vincent Vinciguerra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2020
Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal Cancer
Jeeshan Jiffry, Thongthai Thavornwatanayong, Devika Rao, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 182) with videos related to
Sort By:
Page
of 19
Oncotarget
|
April 29, 2016
Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling
Benjamin Y Owusu, Namita Bansal, Phanindra K M Venukadasula, et al.
Gynecologic Oncology
|
July 24, 2013
Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: a single institution experience from 1999 to 2010
June Y Hou, Santiago Aparo, Mohammad Ghalib, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
October 12, 2022
Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma
Ana Acuna-Villaorduna, Viswanathan Shankar, Michael Wysota, et al.
Investigational New Drugs
|
August 21, 2024
Targeting multiple receptor tyrosine kinases with sitravatinib: A Phase 1b study in advanced renal cell carcinoma and castrate-resistant prostate cancer
Shubham Pant, Byoung Chul Cho, Christos E Kyriakopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2010
Phase II study on the addition of ASA404 (vadimezan; 5,6-dimethylxanthenone-4-acetic acid) to docetaxel in CRMPC
Roberto Pili, Mark A Rosenthal, Paul N Mainwaring, et al.
Molecules (Basel, Switzerland)
|
August 27, 2021
Evaluation of the Free Radical Scavenging Activities of Ellagic Acid and Ellagic Acid Peracetate by EPR Spectrometry
Ajit Kumar, Preeti Kaushik, Sandra Incerpi, et al.
Frontiers in Genetics
|
November 17, 2022
Metformin: Activation of 5' AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action
Sanjay Goel, Ravinder Singh, Varinder Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2020
A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma
Sant P Chawla, Sanjay Goel, Warren Chow, et al.
American Journal of Clinical Oncology
|
September 10, 2009
Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma
Anthony P Lam, Joseph A Sparano, Vincent Vinciguerra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2020
Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal Cancer
Jeeshan Jiffry, Thongthai Thavornwatanayong, Devika Rao, et al.
Page
of 19